{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:31:21Z","timestamp":1783355481011,"version":"3.54.6"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P20GM103653-02"],"award-info":[{"award-number":["5P20GM103653-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RL1 NS062415"],"award-info":[{"award-number":["RL1 NS062415"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.brainres.2015.06.018","type":"journal-article","created":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T14:18:19Z","timestamp":1435328299000},"page":"127-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The combination of lithium and l-Dopa\/Carbidopa reduces MPTP-induced abnormal involuntary movements (AIMs) via calpain-1 inhibition in a mouse model: Relevance for Parkinson\u05f3s disease therapy"],"prefix":"10.1016","volume":"1622","author":[{"given":"Carol A.","family":"Lazzara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeccah R.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Rane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie K.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.brainres.2015.06.018_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coph.2007.12.002","article-title":"Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders","volume":"8","author":"Abel","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.brainres.2015.06.018_bib2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"Ahlskog","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2015.06.018_bib3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.parkreldis.2007.09.005","article-title":"Activation of the calpain\/cdk5\/p25 pathway in the girus cinguli in Parkinson\u05f3s disease","volume":"14","author":"Alvira","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.brainres.2015.06.018_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0306-4522(91)90420-S","article-title":"The effect of l-dopa and carbidopa treatment on the survival of rat fetal dopamine grafts assessed by tyrosine hydroxylase immunohistochemistry and [3H]mazindol autoradiography","volume":"43","author":"Blunt","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2015.06.018_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1601-183X.2007.00342.x","article-title":"Genetic findings in Parkinson\u05f3s disease and translation into treatment: a leading role for mitochondria?","volume":"7","author":"Bogaerts","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.brainres.2015.06.018_bib6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/jnnp.2005.083345","article-title":"Treatment with antidepressants and lithium is associated with increased risk of treatment with antiparkinson drugs: a pharmacoepidemiological study","volume":"77","author":"Brandt-Christensen","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.brainres.2015.06.018_bib7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2174\/138920009788898028","article-title":"Calpains as a target for therapy of neurodegenerative diseases: putative role of lithium","volume":"10","author":"Camins","year":"2009","journal-title":"Curr. Drug Metab."},{"issue":"3","key":"10.1016\/j.brainres.2015.06.018_bib8","first-page":"123","article-title":"l-dopa-carbidopa: combined therapy for the treatment of Parkinson\u05f3s disease","volume":"37","author":"Celesia","year":"1976","journal-title":"Dis. Nerv. Syst."},{"key":"10.1016\/j.brainres.2015.06.018_bib9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.nbd.2011.10.011","article-title":"Striatal inhibition of calpains prevents levodopa-induced neurochemical changes and abnormal involuntary movements in the hemiparkinsonian rat model","volume":"45","author":"Chagniel","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2015.06.018_bib10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ana.410120410","article-title":"Treatment of the \u201con\u2013off\u201d phenomenon in Parkinsonism with lithium carbonate","volume":"12","author":"Coffey","year":"1982","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2015.06.018_bib11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neuropharm.2008.09.012","article-title":"Evidence of calpain\/cdk5 pathway inhibition by lithium in 3-nitropropionic acid toxicity in vivo and in vitro","volume":"56","author":"Crespo-Biel","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2015.06.018_bib12","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1523\/JNEUROSCI.23-10-04081.2003","article-title":"Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson\u05f3s disease","volume":"23","author":"Crocker","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2015.06.018_bib13","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1212\/WNL.54.5.21A","article-title":"Prevalence of Parkinson\u05f3s disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group","volume":"54","author":"de Rijk","year":"2000","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.brainres.2015.06.018_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10571-013-9907-x","article-title":"Lithium\u05f3s gene expression profile, relevance to neuroprotection A cDNA microarray study","volume":"33","author":"Farah","year":"2013","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2015.06.018_bib15","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0306-4522(02)00205-1","article-title":"Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl\/6 mice: behavioural and histopathological characterisation","volume":"114","author":"Fernagut","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2015.06.018_bib16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.nbd.2009.10.017","article-title":"A systematic study of brainstem motor nuclei in a mouse model of ALS, the effects of lithium","volume":"37","author":"Ferrucci","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2015.06.018_bib17","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.neuroscience.2005.04.061","article-title":"Implication of cyclin-dependent kinase 5 in the neuroprotective properties of lithium","volume":"134","author":"Jorda","year":"2005","journal-title":"Neuroscience"},{"issue":"272","key":"10.1016\/j.brainres.2015.06.018_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuroscience.2014.04.039","article-title":"Downregulation of miR-124 in MPTP-treated mouse model of Parkinson\u05f3s disease and MPP iodide-treated MN9D cells modulates the expression of the calpain\/cdk5 pathway proteins","volume":"11","author":"Kanagaraj","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2015.06.018_bib19","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/jnr.22700","article-title":"Lithium protects against oxidative stress-mediated cell death in alpha-synuclein-overexpressing in vitro and in vivo models of Parkinson\u05f3s disease","volume":"89","author":"Kim","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2015.06.018_bib20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.neuroscience.2010.10.072","article-title":"Inducible dopaminergic glutathione depletion in an alpha-synuclein transgenic mouse model results in age-related olfactory dysfunction","volume":"172","author":"Kim","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2015.06.018_bib21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.tox.2008.02.007","article-title":"Inhibition of glycogen synthase kinase-3 reduces l-dopa-induced neurotoxicity","volume":"247","author":"Koh","year":"2008","journal-title":"Toxicology"},{"issue":"20","key":"10.1016\/j.brainres.2015.06.018_bib22","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/hmg\/ddl243","article-title":"Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity","volume":"15","author":"Kontopoulos","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainres.2015.06.018_bib23","doi-asserted-by":"crossref","first-page":"17166","DOI":"10.1074\/jbc.M907757199","article-title":"Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25","volume":"275","author":"Kusakawa","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2015.06.018_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1034\/j.1399-5618.2002.40201.x","article-title":"Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection","volume":"4","author":"Li","year":"2002","journal-title":"Bipolar Disord."},{"issue":"1591","key":"10.1016\/j.brainres.2015.06.018_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainres.2014.10.032","article-title":"Lithium prevents parkinsonian behavioral and striatal phenotypes in an aged parkin mutant transgenic mouse model","volume":"3","author":"Lieu","year":"2014","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.brainres.2015.06.018_bib26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1074\/jbc.M705028200","article-title":"Pharmacogenetic analysis of lithium-induced delayed aging in Caenorhabditis elegans","volume":"283","author":"McColl","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2015.06.018_bib27","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0306-4522(96)00100-5","article-title":"Increased M-calpain expression in the mesencephalon of patients with Parkinson\u05f3s disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?","volume":"73","author":"Mouatt-Prigent","year":"1996","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.brainres.2015.06.018_bib28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1017\/S1461145712000132","article-title":"Neuroprotective effects of chronic exposure of SH-SY5Y to low lithium concentration involve glycolysis stimulation, extracellular pyruvate accumulation and resistance to oxidative stress","volume":"16","author":"Nciri","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2015.06.018_bib29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00004714-200210000-00001","article-title":"Have we undersold lithium for bipolar disorder?","volume":"22","author":"Pies","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.brainres.2015.06.018_bib30","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s10534-011-9433-6","article-title":"Neuroprotective and neurotrophic effects of long term lithium treatment in mouse brain","volume":"24","author":"Riadh","year":"2011","journal-title":"Biometals"},{"key":"10.1016\/j.brainres.2015.06.018_bib31","doi-asserted-by":"crossref","first-page":"42722","DOI":"10.1074\/jbc.M106583200","article-title":"Inhibition of 20S and 26S proteasome activity by lithium chloride: impact on the differentiation of leukemia cells by all-trans retinoic acid","volume":"276","author":"Rice","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2015.06.018_bib32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.nbd.2013.09.014","article-title":"Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway","volume":"62","author":"Riverol","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"24","key":"10.1016\/j.brainres.2015.06.018_bib33","first-page":"6537","volume":"22","author":"Rouaux","year":"2003","journal-title":"Critical loss of CBP\/p300 histone acetylase activity by caspase-6 during neurodegeneration"},{"issue":"4","key":"10.1016\/j.brainres.2015.06.018_bib34","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.cdd.4401769","article-title":"HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis","volume":"13","author":"Saha","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.brainres.2015.06.018_bib35","first-page":"231","article-title":"Lithium intoxication-induced acute parkinsonism complicated with hyperparathyroidism and nephrogenic diabetes insipidus: report of a case","volume":"16","author":"Shen","year":"2007","journal-title":"Acta Neurol. Taiwan."},{"key":"10.1016\/j.brainres.2015.06.018_bib36","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1471-4159.2009.06381.x","article-title":"Neuroprotective effect of l-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson\u05f3s disease: a direct comparison study","volume":"111","author":"Shin","year":"2009","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.brainres.2015.06.018_bib37","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.freeradbiomed.2012.05.024","article-title":"Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: implications for Parkinson\u05f3s disease","volume":"53","author":"Siddiqui","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.brainres.2015.06.018_bib38","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0031-6989(76)90049-7","article-title":"Antagonistic effect of lithium chloride on l-dopa-induced locomotor activity in rats","volume":"8","author":"Smith","year":"1976","journal-title":"Pharmacol. Res. Commun."},{"issue":"2","key":"10.1016\/j.brainres.2015.06.018_bib39","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1523\/JNEUROSCI.2875-05.2006","article-title":"Calpain-regulated p35\/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2","volume":"26","author":"Smith","year":"2006","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.brainres.2015.06.018_bib40","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1185\/03007997809110209","article-title":"A comparative clinical investigation of the therapeutic effect of levodopa alone and in combination with a decarboxylase inhibitor (carbidopa) in cases of Parkinson\u05f3s disease","volume":"5","author":"Wajsbort","year":"1978","journal-title":"Curr. Med. Res. Opin."},{"issue":"41","key":"10.1016\/j.brainres.2015.06.018_bib41","doi-asserted-by":"crossref","first-page":"34246","DOI":"10.1074\/jbc.M112.367540","article-title":"Activation of transcription factor MEF2D by bis(3)-cognitin protects dopaminergic neurons and ameliorates Parkinsonian motor defects","volume":"287","author":"Yao","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2015.06.018_bib42","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.neuropharm.2004.02.005","article-title":"Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax","volume":"46","author":"Youdim","year":"2004","journal-title":"Neuropharmacology"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899315004898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899315004898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T15:09:59Z","timestamp":1652627399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899315004898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":42,"alternative-id":["S0006899315004898"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2015.06.018","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The combination of lithium and l-Dopa\/Carbidopa reduces MPTP-induced abnormal involuntary movements (AIMs) via calpain-1 inhibition in a mouse model: Relevance for Parkinson\u05f3s disease therapy","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2015.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}